The Blinc Group And Think20 Labs Announce Research Partnership Focused On Cannabis Vaping Emissions

Vape Science

NEW YORK: The Blinc Group, the leading provider of customized vaping solutions for the Cannabis industry, and Think20 Labs, an analytical testing laboratory for Hemp and Cannabis, announced a research partnership. The objective of this research is to develop a vaping apparatus that helps identify possible dangerous compounds that are inhaled by consumers. More in-depth research will be conducted looking at how the chemicals in the matrices break down as they are vaporized while also analyzing which products can be recommended for safe consumption.

The research partnership combines The Blinc Group’s deep experience in vaping technologies with Think20 Labs’s expertise in pharmaceutical-grade analysis. The Blinc Group’s participation will be headed by the product standards work of Arnaud Dumas de Rauly, CEO of The Blinc Group, Chairman of the ISO Standards on Vaping Products and Chairman of CEN Standards on Vaping Products, and Think20 Labs’s participation will be managed by Conor Jenkins, the scientific director and lead bioinformatician of Think 20 Labs.

Research, development, and implementation of standardized test methods will include, among others, emissions of cannabinoids, terpenes, VOCs, carbonyl compounds, nitrosamines, and heavy metals.

“We are delighted to be joining forces with the forward-thinking science team at Think20 Labs, to research the creation of innovative, safe and tested cannabis vaping products. The Blinc Group and Think20 Labs share a commitment to responsible product development, based on science and experience, in order to address the current vaping issues. We look forward to beginning our work on this important partnership as The Blinc Group continues to strive for a professional, transparent, and sensibly-regulated cannabis industry,” said Arnaud Dumas de Rauly, CEO of The Blinc Group.

Conor Jenkins states: “The overall goal is to drive the regulations regarding these products and informing regulatory bodies of our findings in hopes that we can show an area that has been dangerously overlooked in this field.”

Read full article @ PRN

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>